Mustang Bio, Inc. (NASDAQ:MBIO) People

Mustang Bio, Inc.

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Michael S. Weiss
Other companies: Checkpoint Therapeutics Inc (Director · Since at least Sep 9, 2016); Fortress Biotech, Inc. (Executive Vice Chairman, Strategic Development · Since at least Jan 1, 2016); TG Therapeutics, Inc. (Chairman, President, and Chief Executive Officer · Since at least Dec 31, 2015); Avenue Therapeutics, Inc. (Director · Mar 13, 2017 – Aug 7, 2018 · Past); National Holdings Corporation (Director · Sep 12, 2016 – Sep 12, 2016 · Past)
Chairman of the Board of Directors · Since at least Sep 26, 2016
Lindsay A. Rosenwald
Other companies: Avenue Therapeutics, Inc. (Director · Since at least Sep 23, 2024); Checkpoint Therapeutics Inc (Director · Since at least May 14, 2024); Journey Medical Corporation (Director · Since at least Mar 22, 2024); Fortress Biotech, Inc. (PRESIDENT, CEO & CHAIRMAN, Director · Since at least Nov 14, 2023)
Director · Since at least Nov 5, 2026
Neil Herskowitz
Other companies: Journey Medical Corporation (Director · Since at least Nov 16, 2021); Checkpoint Therapeutics Inc (Director · Since at least Jun 14, 2018); Avenue Therapeutics, Inc. (Director · Since at least Oct 9, 2017); National Holdings Corporation (Director · Feb 12, 2018 – Feb 12, 2018 · Past)
Director · Since at least Jun 14, 2018
David Jin
Other companies: Fortress Biotech, Inc. (Chief Financial Officer and Head of Corporate Development · Since at least Aug 16, 2022); Avenue Therapeutics, Inc. (Interim Chief Financial Officer and Chief Operating Officer · Since at least May 11, 2022)
Director · Since at least Oct 23, 2024
James B Murphy
Other companies: Decibel Therapeutics Inc (See Remarks · Oct 7, 2022 – Oct 7, 2022 · Past)
Interim CFO · Jan 19, 2024 – Jan 19, 2024 · Past
Adam J. ChillDirector · Since at least Dec 30, 2025
Greg FurrowChief Quality Officer · Since at least Nov 4, 2026
Manuel LitchmanPresident, Chief Executive Officer and Director · Since at least Apr 24, 2017
Michael J. ZelefskyDirector · Since at least Jul 29, 2022
Peter CarneySee Remarks · Dec 11, 2023 – Dec 11, 2023 · Past